Abstract:
Nanoparticles that reveal pancreatic cancer cells in mice have been developed in the laboratory of Ralph Weissleder at Harvard Medical School. Tools for early detection of pancreatic cancer in humans are lacking, and the nanoparticles may be a step toward better diagnosis of this deadly disease.